Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
Nokia’s Acquisition of Infinera
Takeda’s $75 Million Investment in Ascentage Pharma
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
Aledade’s Acquisition of Medical Advantage
Wilson Sonsini Goodrich & Rosati advised Aledade on the transaction. Aledade, the nation’s largest and most successful network of physician-led value-based care, announced that it has...
Bakkt’s Common Stock Offerings
Wilson Sonsini Goodrich & Rosati advised Bakkt Holdings, Inc. on the transaction, and Goodwin Procter advised the placement agent. Bakkt Holdings, Inc. (Bakkt) (NYSE: BKKT), a...
Redwood Materials’ $1 Billion Series D Financing Round
Wilson Sonsini Goodrich & Rosati advised Redwood Materials on the transaction. Redwood Materials announced the completion of its most recent equity funding round, in which the company...
Thoma Bravo’s $2.4 Billion Acquisition of Talend
Wilson Sonsini Goodrich & Rosati, P.C. and Gide Loyrette Nouel A.A.R.P.I. advised Talend, while Kirkland & Ellis, LLP, Jeantet and Houthoff advised Thoma Bravo on the...
Marqeta’s $1.2 Billion IPO
Wilson Sonsini Goodrich & Rosati advised the underwriters on the deal while Goodwin Procter LLP represented Marqeta, Inc. Marqeta announced the pricing of its initial public...
4D pharma plc’s Merger with Longevity Acquisition Corporation
Wilson Sonsini Goodrich & Rosati and Pinsent Masons advised 4D pharma plc on the deal. 4D pharma plc, a Leeds, UK-based pharmaceutical company leading the development...
Alussa Energy’s Business Combination Agreement With Freyr AS
Wiersholm and Elvinger Hoss Prussen assisted Alussa Energy on the deal while Wilson Sonsini Goodrich & Rosati and Arendt have advised FREYR AS on the deal....